Status:
COMPLETED
In Market Utilisation of Liraglutide Used for Weight Management in the UK: a Study in the CPRD Primary Care Database
Lead Sponsor:
Novo Nordisk A/S
Conditions:
Obesity
Overweight
Eligibility:
All Genders
Brief Summary
This study is conducted in Europe. The aim of this study is to investigate the usage of liraglutide for weight management in clinical practice using the CPRD (Clinical Practice Research Datalink) prim...
Eligibility Criteria
Inclusion
- New initiators of liraglutide (unbranded, or branded prescription, i.e. Saxenda® or Victoza®), who have no liraglutide prescriptions in the twelve months prior to index date (time of first prescription). Patients must be research standard (registered as "acceptable" in the database) with at least one year of up-to-standard registration prior to their index date
Exclusion
- Not applicable
Key Trial Info
Start Date :
April 20 2018
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 12 2022
Estimated Enrollment :
105 Patients enrolled
Trial Details
Trial ID
NCT03479762
Start Date
April 20 2018
End Date
September 12 2022
Last Update
November 25 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Novo Nordisk Investigational Site
Soeborg, Denmark, 2860